Asian Spectator

New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration

  • Written by ACN Newswire - Press Releases

New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration

HONG KONG, May 26, 2020 - (ACN Newswire) - Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative R&D driven pharmaceutical conglomerate in the PRC, has announced that the new drug application of the anti PD-1 monoclonal antibody drug (generic name: Penpulimab; R&D code: AK105) jointly developed and commercialized with Akeso, Inc. (HKEX: 9926), a biopharmaceutical company committed to R&D, production and commercialization of affordable innovative antibody drugs for patients worldwide, has been accepted by the National Medical Products Administration of the PRC, for the treatment of patients with relapsed or refractory Classical Hodgkin's Lymphoma.

Classical Hodgkin Lymphoma (cHL) is a B-cell lymphoma, and is also one of the most common malignancies among young people. It has a single modal age distribution in China with a peak at around 40 years of age . cHL is one of the few tumors that can be cured, and the most common therapy is chemotherapy plus radiotherapy, with the 5-year survival rate of patients as high as over 80%. Although the first-line chemotherapy has a high clinical cure rate, a considerable portion of patients are insensitive to chemotherapy and approximately 5% to 10% of patients do not respond to the initial treatment .

Professor Zhu Jun, Co-principal investigator of the lead unit Beijing Cancer Hospital is full of expectations for such a differentiated anti PD-1 monoclonal product and said, through bioengineering technology, Penpulimab completely eliminate the binding activity of Fc receptors and avoid the antibody-dependent cell-mediated cytotoxicity (ADCC) effect. At the same time, compared with other drugs available in the market working on the same target, it has a slower rate of antigen binding and dissociation, which makes the biological effect stronger and improves its anti-tumor activity.

Co-lead researcher Professor Song Yuqin, Director of Lymphoma Department at Peking University Cancer Hospital said, in clinical trial, Penpulimab was observed with gratifying therapeutic data and good safety. As a clinician, Professor Song hoped that Penpulimab can be launched to the market soon, which will benefit more patients and their families.

About Sino Biopharmaceutical Limited (HKEX: 1177)Sino Biopharmaceutical Limited is a leading, innovative R&D driven pharmaceutical conglomerate in the PRC. Its business encompasses a fully-integrated chain which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemical medicines for treating tumors, liver diseases, respiratory system diseases, anti-infectious diseases and orthopedic diseases.

Sino Biopharm is a constituent stock of the following indices: MSCI Global Standard Indices - MSCI China Index, Hang Seng Index, Hang Seng Index - Commerce & Industry, Hang Seng Composite Index, Hang Seng Composite Industry Index - Consumer Goods, Hang Seng Composite LargeCap Index, Hang Seng Composite LargeCap & MidCap Index, Hang Seng China (Hong Kong-listed) 100 Index and Hang Seng Stock Connect Hong Kong Index. Sino Biopharm was ranked as one of "Asia's Fab 50 Companies" by Forbes Asia for three consecutive years in 2016, 2017 and 2018. http://www.sinobiopharm.com/.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

50 Best Releases Its First-Ever E-cookbook Featuring Recipes F...

LONDON, July 2, 2020 /PRNewswire-AsiaNet/ -- The organisation behind The World's 50 Best Restaurants has released its first ever e-cookbook, entitled Home Comforts: simple lockdown recipes f...

Economics Expert David L. Sunding Elected as President of The ...

BOSTON, July 2, 2020 /PRNewswire-AsiaNet/ -- The Brattle Group is pleased to announce that David L. Sunding has been elected as its next President, effective July 1, 2020. Dr. Sunding succee...

Awards USD$1 Million Prize, HUAWEI HMS App Innovation Contest ...

SHENZHEN, China, July 1, 2020 /PRNewswire-AsiaNet/ -- ·Top developers across five regions invited to create innovative apps by integrating with HMS Core, a full suite of Huawei's Chip...

TUMI Builds On Legacy Of Innovation Through Sustainability

NEW YORK, July 1, 2020 /PRNewswire-AsiaNet/-- With a heritage of producing the highest quality products, today TUMI, the leading international travel and lifestyle brand, takes the next step...

Toyota Launches New Acceleration Suppression System

Toyota City, Japan, Jul 1, 2020 - (JCN Newswire) - Toyota Motor Corporation (Toyota) announced today that it has developed a new Acceleration Suppression System, in addition to its existing...

Tohoku University and NEC Collaborate to Accelerate the Development of Composite Materials for Aircraft

TOKYO, Jul 1, 2020 - (JCN Newswire) - Tohoku University Graduate School of Engineering, Graduate School of Information Sciences, and NEC Corporation today announced the start of research an...

Myanmar Citizens Bank to issue MPU-JCB Co-Branded Debit Card in Myanmar

Yangon and Tokyo, Jul 1, 2020 - (ACN Newswire) - Myanmar Citizens Bank (MCB Bank), a listed company on the Yangon Stock Exchange in the Republic of the Union of Myanmar (Myanmar), and JCB I...

GCL SI Supports Floating Solar Power Plant in Persian Gulf

SUZHOU, China, July 1, 2020 /PRNewswire-AsiaNet/ -- Research by the IHS Markit's Floating PV Report 2020 reveals recently that the floating solar power installations are set to jump by 143% ...

Handheld Announces Major Upgrades to its Popular NAUTIZ X2 All...

LIDKÖPING, Sweden, July 1, 2020 /PRNewswire-AsiaNet/-- Handheld Group [ https://www.handheldgroup.com/?utm_source=PRNewsWire&utm_medium=PressRelease&utm_campaign=NautizX2Update]...

9 in 10 Employers Say Data Skills Gap Impedes Optimal Productivity Amid Growing Reliance On Data-Driven Decision Making

94% find themselves using data to make business decisions more so as compared to a year ago However, 93% believe their workforce is not achieving optimal productivity due to a lack in data s...

Closing of transaction - Barry Callebaut completes acquisition...

ZURICH and SINGAPORE, July 1, 2020 /PRNewswire-AsiaNet/ -- Acquisition establishes Barry Callebaut's direct presence and manufacturing capacity in Australia to cater for the Australian and N...

Next Story Group Launches Safe With Us

SINGAPORE, July 1, 2020 /PRNewswire-AsiaNet/ -- - Enhanced hygiene and safety protocols in hotels and Kafnu properties - International hospitality group Next Story Group has launched a new h...

How to Build Back a Low-Carbon Economy Globally: RMI Stimulus ...

BOULDER, Colorado, July 1, 2020 /PRNewswire-AsiaNet/ -- --Responding to the current economic downturn can simultaneously benefit the economy, the environment, and our communities. RMI's Gree...

Evolution Wellness Launches Licensing Programme for Asia’s Smartest Gym

Targets 1000 licensed clubs to serve a global audience of millions KUALA LUMPUR, MALAYSIA - Media OutReach -  1 July 2020 - Evolution Wellness, Asia's leading health club operator ...

Far East Hospitality Makes Bold Move with Official Opening of ...

SINGAPORE, July 1, 2020 /PRNewswire-AsiaNet/ -- Far East Hospitality, one of the leading operators of hotels and serviced residences, today announced that its Far East Village Hotel Ariake i...

Remap-Cap to Partner With Eisai on Innovative Trial to Combat COVID

TOKYO, Jul 1, 2020 - (JCN Newswire) - The Global Coalition for Adaptive Research (GCAR), in collaboration with UPMC (University of Pittsburgh Medical Center), and Eisai announced today that...

INEOS Automotive Reveals the Design of Its Upcoming 4x4, the G...

LONDON, July 1, 2020 /PRNewswire-AsiaNet/ -- - "Form follows function" in an engineering-led design process focused on delivering a vehicle to do a job- Development programme moving forward...

HUAWEI HMS App Innovation Contest, AppsUP goes global

SINGAPORE, July 1, 2020/PRNewswire-AsiaNet/-- US$200,000 in cash and US$200,000 in Huawei Cloud resources up for grabs in Asia Pacific Developers around the world are being invited to put th...

SecurityHQ, Formerly Known as Si Consult, Reveals New Brand Id...

LONDON, July 1, 2020 /PRNewswire-AsiaNet/ -- SecurityHQ [http://www.securityhq.com/], formerly known as Si Consult, the leading provider in managed security services, announced today the lau...



News Company Media Core

Content & Technology Connecting Global Audiences

More Information - Less Opinion